DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hytrin (Terazosin Hydrochloride) - Published Studies

 
 



Hytrin Related Published Studies

Well-designed clinical trials related to Hytrin (Terazosin)

Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial. [2013]

Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial. [2011]

[Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome] [2009.08]

Efficacy of combined amlodipine/terazosin therapy in male hypertensive patients with lower urinary tract symptoms: a randomized, double-blind clinical trial. [2009.07]

[Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention] [2009.05]

Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial. [2008.04]

Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study. [2007.03.05]

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study. [2006]

Comparative evaluation of Prostina and terazosin in the treatment of benign prostatic hyperplasia. [2005.02]

Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. [2004.11]

Terazosin and doxazosin in the treatment of BPH: results of a randomized study with crossover in non-responders. [2004]

Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. [2003.02]

[Effects of terazosine and atenolol on serum lipids in essential hypertension] [2002.09]

[A randomized comparative study assessing once versus twice a day treatment of benign prostatic hyperplasia with terazosin] [2001.02]

[The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy] [2001.01]

Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. [2001]

The relationship between terazosin dose and blood pressure response in hypertensive patients. [2000.10]

Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia. [2000.06]

[Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group] [2000.04]

A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients. [2000.04]

The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study. [2000.04]

Terazosine and tamsulosin in non bacterial prostatitis: a randomized placebo-controlled study. [1999.12]

A comparison of the antagonistic activities of tamsulosin and terazosin against human vascular alpha1-adrenoceptors. [1999.07]

Effects of terazosin therapy on blood pressure in men with benign prostatic hyperplasia concurrently treated with other antihypertensive medications. [1999.07]

Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359. [1999.06.01]

Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension. [1999.04]

Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin. [1999.01]

Pharmacokinetic interaction between finasteride and terazosin, but not finasteride and doxazosin. [1998.11]

Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men. [1998.09]

Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension. [1998.06]

Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics. [1998.01]

Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group. [1998]

A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. [1998]

Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. [1997.10]

Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-month placebo-controlled study with terazosin. HYCAT Investigator Group. Hytrin Community Assessment Trial. [1997.10]

Terazosin blockade of nicotine-induced skin flap necrosis in the rat. [1997.08]

Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies. [1997.01]

Assessment of the pharmacokinetic-pharmacodynamic interaction between terazosin and finasteride. [1996.12]

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. [1996.08.22]

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia. [1996.03]

The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia. [1996.02]

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group. [1996.02]

The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. The ITT Group. [1996]

Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms. [1995.07]

Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions. [1995.02]

Terazosin and doxazosin in normotensive men with symptomatic prostatism: a pilot study to determine the effect of dosing regimen on efficacy and safety. [1995]

Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis. [1994.07]

[Pressure and metabolic effects of terazosin in essential hypertension] [1994.06]

[The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura] [1994.04]

Use of terazosin in prostatodynia and validation of a symptom score questionnaire. [1994.04]

Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study Group. [1993.09]

Comparison of the effects of terazosin and enalapril on laboratory stress testing blood pressure in patients with essential hypertension. [1993.05]

A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension. [1992.12]

Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience in Italy. [1992.11]

Terazosin in the treatment of benign prostatic hyperplasia: the United States experience. [1992.11]

Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial. [1992.11]

Placebo-controlled study of terazosin in the treatment of benign prostatic hyperplasia with 2-year follow-up. [1992.11]

A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. [1992.11]

Double-blind placebo-controlled trial of terazosin effect on blood pressure and urinary output of dopamine in hypertensive patients. [1992.09]

Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension. [1992.06]

Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension. [1992.04]

The safety and efficacy of terazosin in the treatment of essential hypertension in blacks. [1991.09]

Antihypertensive dose-response relationships: studies with the selective alpha 1-blocking agent terazosin. [1991.09]

Efficacy of once-a-day terazosin in benign prostatic hyperplasia: a randomized, double-blind placebo-controlled clinical trial. [1990]

The effects of terazosin and methyclothiazide on blood pressure and serum lipids. [1989.04]

Concomitant administration of terazosin and atenolol for the treatment of essential hypertension. [1988.03]

Well-designed clinical trials possibly related to Hytrin (Terazosin)

Finasteride for benign prostatic hyperplasia. [2010.10.06]

Symptomatic comparison in efficacy on patients with benign prostatic hyperplasia treated with two therapeutic approaches. [2010.02]

Role of alpha adrenergic blocker in the management of posterior urethral valves. [2009.12]

Role of alpha adrenergic blocker in the management of posterior urethral valves. [2009.09.01]

[Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome] [2009.09]

Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophy. [2009.08.01]

A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results. [2009.07]

Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones. [2009]

[Efficacy of electroacupuncture in treating 93 patients with benign prostatic hyperplasia] [2008.11]

Role of alpha1-blockers in chronic prostatitis syndromes. [2008.03]

[Comparison of different drugs on the treatment of benign prostate hyperplasia] [2007.07.15]

LC-MS determination and relative bioavailability of doxazosin mesylate tablets in healthy Chinese male volunteers. [2007.02.19]

The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. [2005.06]

[Serum nitric oxide and D-dimer before and after administering antihypertensive drugs in essential hypertension] [2003.08]

Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. [2002.10]

[Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis] [2002]

Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. [2001.01]

Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia. [1999.01]

Comparative efficacies of a calcium antagonist and an alpha1 blocker in elderly hypertensive patients with stroke. [1998.10]

The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. [1998.10]

Treatment of idiopathic oligozoospermia with an alpha-blocker: a placebo-controlled double-blind trial. [1997.09]

Beneficial effect of alpha-blocker on hemorheology in patients with essential hypertension. [1997.08]

Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. [1995]

Other research related to Hytrin (Terazosin)

Efficacy and safety of propiverine and terazosine combination for one year in male patients with luts and detrusor overactivity. [2013]

Effect of terazosin on sweating in patients with major depressive disorder receiving sertraline: a randomized controlled trial. [2013]

WITHDRAWN: Terazosin for benign prostatic hyperplasia. [2011.09.07]

Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity. [2009.12]

Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review. [2009.08]

Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line. [2009.04.08]

Combined use of melatonin and terazosin restores bladder contractility in rabbits with partial outlet obstruction. [2008.08]

Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume. [2008.06]

Acute generalized exanthematous pustulosis caused by terazosin hydrochloride. [2008.04]

Pharmacokinetic and pharmacodynamic modelling of arterial haemodynamic effects of terazosin in healthy volunteers. [2008]

High-dose terazosin therapy (5mg) in Korean patients with lower urinary tract symptoms with or without concomitant hypertension: a prospective, open-label study. [2007.12.31]

New-onset priapism associated with ingestion of terazosin in an otherwise healthy man. [2007.11]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017